« Previous
Next »
American Journal of Kidney Diseases
Volume 48, Issue 4
, Pages
537-545
, October 2006
The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2006.06.011 on August 29, 2006.Support: The costs for measurement of iron storage indices were defrayed by a grant from Jansen-Cilag (manufacturer of epoetin). The costs of erythropoietin levels were defrayed by a grant from Amgen (manufacturers of darbepoetin). Neither party had a role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication. M.C.T. and G.J. were both members of the Jannsen-Cilag Endocrinology advisory panel (2001 to 2002). Potential conflicts of interest: None.
PII: S0272-6386(06)01082-1
doi: 10.1053/j.ajkd.2006.06.011
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 48, Issue 4
, Pages
537-545
, October 2006
